Had a bad reaction to Mounjaro? Here's how to tell what matters

The reactions most people have, and why they usually settle

Ask the prescribers at any GLP-1 clinic what question comes up most and it is some version of: "Is this normal?" Stomach upset is genuinely common on tirzepatide. Nausea is the most frequently reported; loose stools, constipation, indigestion, burping and fatigue follow close behind. Headaches and dizziness appear in a smaller group. These effects tend to cluster around the first injection of a new dose, then ease off over the following week or so. For many people they are mildest at 2.5mg and only reappear briefly when the dose increases.

None of that means you have to simply endure them. Small practical adjustments, eating more slowly, choosing lower-fat meals, staying well hydrated, mean the adjustment window is more manageable for most people. Your prescriber and the Patient Information Leaflet included with your medication are the right places to get advice tailored to what you are experiencing. If discomfort feels unmanageable or is stopping you eating and drinking, contacting your clinical team rather than pushing through is entirely reasonable. Our Mounjaro side effects overview covers this territory in more detail if you want a fuller picture before speaking to anyone.

Injection-site reactions, redness, mild swelling or itching where you inject, are also reported fairly regularly. Rotating your injection site between the abdomen, thigh and upper arm at each dose reduces the chance of local skin irritation building up. A broader explanation of what Mounjaro injection site reactions look like, and when they are worth flagging, may help you assess what you are seeing.

When a reaction needs urgent medical attention

The decision to seek immediate help should not be difficult if you know what to look for. Some reactions are rare but serious, and waiting to see whether they improve is the wrong call.

Pancreatitis is the one that gets most clinical attention. In January 2026 the MHRA issued a Drug Safety Update specifically reminding prescribers and patients that acute pancreatitis, though infrequent, is a known risk with GLP-1 medicines: the symptom to act on is severe stomach pain, persistent rather than passing, that may spread toward the back, with or without vomiting. If that describes what you are feeling, stop the injection and get medical help the same day, either through your GP, urgent treatment centre, or 111. Do not simply increase your water intake and rest.

An allergic reaction is a different category of urgency. Swelling of the lips, face, tongue or throat, difficulty swallowing, a spreading rash, or a sudden drop in blood pressure that makes you feel faint: any combination of those is a potential anaphylactic reaction and needs 999, not a web search. For a detailed breakdown of the signs that distinguish an allergic response from an ordinary skin reaction, the allergic reaction to Mounjaro page sets that out clearly.

Gallbladder problems, including gallstones and gallbladder inflammation, are also listed as a known risk. Pain in the upper right abdomen, fever, or yellowing of the skin or eyes means calling your GP or 111. Severe dehydration from persistent vomiting or diarrhoea, especially if you cannot keep fluids down, also warrants same-day contact with a clinician.

Reactions that are different from side effects: things to watch at skin level

Some people notice skin changes that sit in a middle ground: not clearly an emergency, but not quite "just the medicine settling". Injection-site lumps that do not resolve, persistent redness spreading beyond the injection point, or discomfort that worsens rather than fades over 48 hours are all worth sending a photo of to your clinical team.

Broader skin reactions, a rash appearing away from the injection site, unusual bruising, or hives across the body, are less common but documented. These can sometimes indicate a hypersensitivity response that needs the dose reviewed. The skin reaction to Mounjaro page covers the range of dermatological responses that have been reported, from minor to those that require clinical review.

The NHS patient guidance for tirzepatide distinguishes between reactions to report to a doctor "as soon as possible" and those that can wait for a routine conversation. That distinction is a practical guide worth reading alongside the Patient Information Leaflet in your box.

What to do if you are unsure whether to continue

Stopping Mounjaro suddenly because a side effect worried you is understandable, though it is a decision worth making with your prescriber rather than alone. Some people stop and restart at the same dose; some move back a step; some need a different plan. The risks and practicalities of stopping Mounjaro are worth reading if that is where your thinking is heading.

If the reaction you experienced was at a particular dose, the pattern of what happens across doses is part of the conversation a prescriber has with you before each repeat. At nume, a named clinician, not an automated system, reviews your case before every order goes out. The consultation covers your experience since the last dose, including any adverse reactions, as standard. If you have questions before you're ready to commit to anything, our free consultation page explains what that process involves. You can also browse the broader context of what Mounjaro is, how it works, and who it suits before deciding anything.

One more practical step: if you suspect your medicine is counterfeit or came from an unverified source, the MHRA's Yellow Card scheme lets you report both adverse reactions and suspect products. A legitimate supply chain matters as much as the medicine itself. For anyone considering where to start if they have not yet begun treatment, our weight loss treatment overview sets out what is licensed in the UK right now.